Daniel Miller

Overview

Accolades

• 

  Pleural Mesothelioma

• 

  Board Certified in Thoracic Surgery

• 

  Hyperthermic Intraperitoneal Chemotherapy

• 

  Minimally Invasive Surgery

As an internationally-renowned specialist, Miller has helped introduce minimally-invasive techniques for complex malignancies and new interventions for metastatic pleural diseases.

He has expertise in aggressive surgery for pleural mesothelioma and advanced lung cancer. He is also skilled in video-assisted thoracoscopic surgery for early-stage disease.

Miller joined Cancer Centers of America (CTCA) in 2014. He was attracted to its patient-centered approach to treatment that has led to its rise in prominence. Today, CTCA is among the country’s leading medical providers.

Over the past two decades, Miller has held several positions and appointments. He was co-director of the Lung Transplant Program at the University of Louisville Hospitals.

He was associate professor of surgery at Mayo Medical School in Rochester, Minnesota, and he directed the Thoracic Oncology Program at the Winship Cancer Institute in Atlanta. He was Chief of Thoracic Surgery at nearby Emory University.

“The most important principle that I follow is that the needs of the patient always come first,” Miller said. “The compassion and dedication of the CTCA staff to the individual needs of the patient is second to none.”

Miller also serves today as Director of Clinical Research for the WellStar Health System. He is also a Professor of Surgery at Georgia Regents University.

Leading-Edge Pleural Mesothelioma Treatment

Miller has worked with mesothelioma patients for more than two decades. He has experience performing both the extrapleural pneumonectomy (EPP) and the pleurectomy/decortication (P/D) surgeries.

He believes strongly in the multimodal approach that combines surgery with chemotherapy and radiation.

He also is one of a select number of surgeons who combines surgery with adjuvant hyperthermic pleural lavage. This technique is designed to eliminate any microscopic tumor cells left behind after surgery.

“I think for all of us who deal with mesothelioma, the number one objective is to have the patient complete tri-modality therapy as planned, which offers the best chance for cure,” he said.

Miller has published more than 130 articles dealing with thoracic malignancies. He has served on the editorial boards for several medical journals, including Chest, Cancer, Lung Cancer and the Journal of Clinical Oncology.

He received his degree from the University of Kentucky School of Medicine. He completed a residency and internship at Georgetown University Hospital in Washington, D.C. He then completed his training with a fellowship at the Mayo Clinic and Mayo Foundation in Rochester, Minnesota.

See More Top Mesothelioma Doctors